A detailed history of Financial Advisory Service, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 315,749 shares of CORT stock, worth $16.5 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
315,749
Previous 315,772 0.01%
Holding current value
$16.5 Million
Previous $10.3 Million 42.37%
% of portfolio
1.24%
Previous 0.93%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$29.51 - $46.26 $678 - $1,063
-23 Reduced 0.01%
315,749 $14.6 Million
Q2 2024

Jul 29, 2024

BUY
$22.21 - $34.48 $97,479 - $151,332
4,389 Added 1.41%
315,772 $10.3 Million
Q1 2024

Apr 29, 2024

BUY
$21.1 - $27.46 $23,041 - $29,986
1,092 Added 0.35%
311,383 $7.84 Million
Q4 2023

Jan 23, 2024

SELL
$24.82 - $32.88 $11,739 - $15,552
-473 Reduced 0.15%
310,291 $10.1 Million
Q3 2023

Oct 23, 2023

SELL
$21.97 - $33.8 $153 - $236
-7 Reduced -0.0%
310,764 $8.47 Million
Q2 2023

Aug 08, 2023

BUY
$21.44 - $25.15 $123,172 - $144,486
5,745 Added 1.88%
310,771 $6.91 Million
Q1 2023

May 11, 2023

SELL
$19.2 - $24.47 $24,000 - $30,587
-1,250 Reduced 0.41%
305,026 $6.61 Million
Q4 2022

Feb 01, 2023

BUY
$19.95 - $29.96 $133,665 - $200,732
6,700 Added 2.24%
306,276 $6.22 Million
Q3 2022

Oct 20, 2022

SELL
$24.7 - $29.12 $5,038 - $5,940
-204 Reduced 0.07%
299,576 $7.68 Million
Q2 2022

Aug 02, 2022

BUY
$17.33 - $25.3 $175,986 - $256,921
10,155 Added 3.51%
299,780 $7.13 Million
Q1 2022

May 04, 2022

BUY
$16.53 - $25.21 $70,797 - $107,974
4,283 Added 1.5%
289,625 $6.52 Million
Q4 2021

Feb 11, 2022

SELL
$17.1 - $23.34 $5,130 - $7,002
-300 Reduced 0.11%
285,342 $5.65 Million
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $72,422 - $82,910
3,680 Added 1.31%
285,642 $5.62 Million
Q2 2021

Jul 29, 2021

BUY
$19.97 - $24.43 $917,042 - $1.12 Million
45,921 Added 19.45%
281,962 $6.2 Million
Q1 2021

May 17, 2021

BUY
$23.49 - $30.56 $352,256 - $458,277
14,996 Added 6.78%
236,041 $5.62 Million
Q4 2020

Feb 10, 2021

BUY
$16.78 - $27.3 $90,863 - $147,829
5,415 Added 2.51%
221,045 $5.78 Million
Q3 2020

Nov 16, 2020

BUY
$12.46 - $19.98 $230,385 - $369,430
18,490 Added 9.38%
215,630 $3.75 Million
Q2 2020

Jul 21, 2020

SELL
$11.0 - $18.26 $58,927 - $97,818
-5,357 Reduced 2.65%
197,140 $3.32 Million
Q1 2020

May 14, 2020

BUY
$10.11 - $14.04 $2.05 Million - $2.84 Million
202,497 New
202,497 $2.41 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.